These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32799746)

  • 1. Validation and comparison of drug eluting stent to bare metal stent for restenosis rates following vertebral artery ostium stenting: A single-center real-world study.
    Li L; Wang X; Yang B; Wang Y; Gao P; Chen Y; Zhu F; Ma Y; Chi H; Zhang X; Bai X; Feng Y; Dmytriw AA; Hong T; Hua Y; Jiao L; Ling F
    Interv Neuroradiol; 2020 Oct; 26(5):629-636. PubMed ID: 32799746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting.
    Maciejewski DR; Pieniazek P; Tekieli L; Paluszek P; Przewlocki T; Tomaszewski T; Machnik R; Trystula M; Legutko J; Kablak-Ziembicka A
    Postepy Kardiol Interwencyjnej; 2019; 15(3):328-337. PubMed ID: 31592257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bare metal vs. drug-eluting stents for extracranial vertebral artery disease: a meta-analysis of nonrandomized comparative studies.
    Langwieser N; Buyer D; Schuster T; Haller B; Laugwitz KL; Ibrahim T
    J Endovasc Ther; 2014 Oct; 21(5):683-92. PubMed ID: 25290797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Drug-Eluting Stent With Bare-Metal Stent in Patients With Symptomatic High-grade Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial.
    Jia B; Zhang X; Ma N; Mo D; Gao F; Sun X; Song L; Liu L; Deng Y; Xu X; Zhang Y; Liu Z; Guan S; Zhang F; Li B; Zheng H; Liu X; Liu Y; Chen K; Shuai J; Wan J; Wang J; Shi X; Li T; Chang B; Liebeskind DS; Yu W; Miao Z;
    JAMA Neurol; 2022 Feb; 79(2):176-184. PubMed ID: 34982098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
    Rathore S; Kinoshita Y; Terashima M; Katoh O; Matsuo H; Tanaka N; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
    EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of drug-eluting balloon in patients with bare-metal or drug-eluting stent restenosis.
    Berta B; Jambrik Z; Kohar K; Szabo G; Ruzsa Z; Molnar L; Barczi G; Geller L; Becker D; Merkely B
    Hellenic J Cardiol; 2014; 55(5):369-77. PubMed ID: 25243435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
    J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting vs. bare metal stents for symptomatic vertebral artery stenosis.
    Song L; Li J; Gu Y; Yu H; Chen B; Guo L; Zhang J
    J Endovasc Ther; 2012 Apr; 19(2):231-8. PubMed ID: 22545889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a Drug-Eluting Stent vs. Bare Metal Stent for the Treatment of Symptomatic Intracranial and Vertebral Artery Stenosis.
    Si JH; Ma N; Gao F; Mo DP; Luo G; Miao ZR
    Front Neurol; 2022; 13():854226. PubMed ID: 35911924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes and influencing factors of in-stent restenosis after stenting for symptomatic stenosis of the vertebral V1 segment.
    Che WQ; Dong H; Jiang XJ; Peng M; Zou YB; Xiong HL; Yang YJ; Gao RL
    J Vasc Surg; 2018 Nov; 68(5):1406-1413. PubMed ID: 29789215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
    Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term clinical outcomes of brachytherapy, bare-metal stenting, and drug-eluting stenting for de novo and in-stent restenosis lesions: five year follow-up.
    Dogdu O; Yarlioglues M; Kaya MG; Tulumen E; Sarli B; Gunebakmaz O; Ardic I; Kalay N; Akpek M; Kelesoglu S; Basar E
    Cardiol J; 2011; 18(6):654-61. PubMed ID: 22113753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of drug-eluting stent implantation for the treatment of in-stent restenosis occurring within bare-metal stent and drug-eluting stent.
    Ge H; Zhang Q; Zhou W; He Q; Han ZH; He B
    J Zhejiang Univ Sci B; 2010 Aug; 11(8):553-60. PubMed ID: 20669344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
    Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
    Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.